69
Views
18
CrossRef citations to date
0
Altmetric
Letter to the Editor

Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma

, , , , , , , & show all
Pages 2235-2238 | Received 01 Apr 2007, Accepted 05 Aug 2007, Published online: 01 Jul 2009

References

  • Levy Y, Brouet J C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994; 93: 424–428
  • Blay J Y, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 1993; 82: 2169–2174
  • Lech-Maranda E, Bienvenu J, Michallet A S, Houot R, Robak T, Coiffier B, et al. Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Netw 2006; 17: 60–66
  • Turner D M, Williams D M, Sankaran D, Lazzarus M, Sinnott P J, Hutchinson I V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1–8
  • Gibson A W, Edberg J C, Wu J, Westendorp R G, Huizinga T W, Kimberly R P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915–3922
  • Lech-Maranda E, Baseggio L, Bienvenu J, Charlot C, Berger F, Rigal D, et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004; 103: 3529–3534
  • Rothman N, Skibola C F, Wang S S, Morgan G, Lan Q, Smith M T, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium. Lancet Oncol 2006; 7: 27–38
  • Lan Q, Zheng T, Rothman N, Zhang Y, Wang S S, Shen M, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006; 107: 4101–4108
  • Purdue M P, Lan Q, Kricker A, Grulich A E, Vajdic C M, Turner J, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 2007; 28: 704–712
  • Coakley G, Mok C C, Hajeer A H, Ollier W ER, Turner D, Sinnott P J, et al. Interelukin-10 promoter polymorphisms in rheumatoid arthrits and Felty's syndrome. Br J Rheumatol 1998; 37: 988–991
  • Ding K, Zhou K, He F, Shen Y. LDA—a java-based linkage disequilibrium analyzer. Bioinformatics 2003; 19: 2147–2148
  • Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–1169
  • Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699–706
  • Reynard M P, Turner D, Navarrete C V. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a north european caucasoid group from the UK. Eur J Immunogenet 2000; 27: 241–249
  • Mok C C, Lanchbury J S, Chan D W, Lau C S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090–1095

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.